New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
Opportunities and challenges in heart rhythm ÌÇÐÄ´«Ã½: Rationale and development of an electrophysiology collaboratory.
ÌÇÐÄ´«Ã½
Opportunities and challenges in heart rhythm ÌÇÐÄ´«Ã½: Rationale and development of an electrophysiology collaboratory. Heart rhythm Nguyen, D. T., Bilchick, K. C., Narayan, S. M., Chung, M. K., Thomas, K. L., Laurita, K. R., Vaseghi, M., Sandhu, R., Chelu, M. G., Kannankeril, P. J., Packer, D. L., McManus, D. D., Verma, A., Singleton, M., Tarakji, K., Al-Khatib, S. M., Kaltman, J. R., Balijepalli, R. C., Van Hare, G. F., Hurwitz, J. L., Russo, A. M., Kusumoto, F. M., Albert, C. M. 2022; 19 (11): 1927-1945Abstract
There are many challenges in the current landscape of electrophysiology (EP) clinical and translational ÌÇÐÄ´«Ã½, including increasing costs and complexity, competing demands, regulatory requirements, and challenges with study implementation. This review seeks to broadly discuss the state of EP ÌÇÐÄ´«Ã½, including challenges and opportunities. Included here are results from a Heart Rhythm Society (HRS) Research Committee member survey detailing HRS members' perspectives regarding both barriers to clinical and translational ÌÇÐÄ´«Ã½ and opportunities to address these challenges. We also provide stakeholder perspectives on barriers and opportunities for future EP ÌÇÐÄ´«Ã½, including input from representatives of the U.S. Food and Drug Administration, industry, and ÌÇÐÄ´«Ã½ funding institutions that participated in a Research Collaboratory Summit convened by HRS. This review further summarizes the experiences of the heart failure and heart valve communities and how they have approached similar challenges in their own fields. We then explore potential solutions, including various models of ÌÇÐÄ´«Ã½ ecosystems designed to identify ÌÇÐÄ´«Ã½ challenges and to coordinate ways to address them in a collaborative fashion in order to optimize innovation, increase efficiency of evidence generation, and advance the development of new therapeutic products. The objectives of the proposed collaborative cardiac EP ÌÇÐÄ´«Ã½ community are to encourage and support scientific discourse, ÌÇÐÄ´«Ã½ efficiency, and evidence generation by exploring collaborative and equitable solutions in which stakeholders within the EP community can interact to address knowledge gaps, innovate, and advance new therapies.
View details for
View details for